Cost-Effectiveness of Aerial Logistics for Maternal and Newborn Health: A Simulation-Based Analysis Grounded in Real-World Evidence from the Ashanti Region in Ghana [0.03%]
基于加纳阿散蒂地区真实世界证据的模拟分析：空中物流用于母婴健康的成本效益如何？
Maria J Ospina-Fadul,Pedro Kremer,Florence Haruna et al.
Maria J Ospina-Fadul et al.
Background: In sub-Saharan Africa, low antenatal care (ANC) coverage and limited access to facility-based deliveries remain key drivers of adverse maternal and newborn health (MNH) outcomes. Inadequate service provision a...
Frequency and Mortality of Adult Meningitis, Pneumonia, or Bacteremia in Colombia from 2015 to 2022: A Retrospective Database Study in a Health Maintenance Organization [0.03%]
2015至2022年哥伦比亚某健康维护组织成人脑膜炎、肺炎或菌血症的发病率和死亡率：一项数据库回顾性研究
Juan M Reyes Sánchez,Carlos Bello,Jhon Bolaños López et al.
Juan M Reyes Sánchez et al.
Background: Meningitis, pneumonia, and bacteremia, prevalent community-acquired diseases that can lead to multi-organ failure, are influenced by age, comorbidities, and living conditions. Despite meningitis surveillance i...
Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study [0.03%]
伊朗囊性纤维化疾病的疾病负担成本研究
Hassan Karami,Shideh Rafati,Maryam Shirvani Shiri et al.
Hassan Karami et al.
Background: Cystic fibrosis (CF) is a rare genetic disorder that places a substantial financial burden on patients, families, and the healthcare system. This study aimed to estimate the economic impact of CF in southern I...
Reasonable Cost for Procedures: An Anonymous Survey of Healthcare Providers [0.03%]
医疗程序的合理成本：医务人员匿名调查报告
David Shin,Carson Cummings,David Cheng et al.
David Shin et al.
Background: The cost of medical procedures in the United States varies dramatically depending on the payment system, including Medicare, Medi-Cal (California's Medicaid program), private insurance, or lien-based payment m...
Real-World Treatment Patterns and Cost of Care in US Ovarian Cancer Patients Undergoing BRCA Testing [0.03%]
美国接受BRCA检测的卵巢癌患者的治疗模式及医疗费用现实世界研究
Srujitha Marupuru,Kristin Moore,Desiree Hall et al.
Srujitha Marupuru et al.
Background: Patients with ovarian cancer incur substantial economic burdens. However, little is known about the differences in metrics such as treatment patterns, healthcare resource utilization (HCRU), and costs between ...
Healthcare Resource Use, Healthcare Costs, and Unmet Needs Among Patients Treated for EGFR-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [0.03%]
EGFR突变的晚期或转移性非小细胞肺癌患者的医疗资源利用、医疗费用和未满足需求
David Waterhouse,Iris Li,Laura Morrison et al.
David Waterhouse et al.
Background: Approximately 17% of patients with non-small cell lung cancer (NSCLC) have epidermal growth factor receptor-mutated (EGFRm) NSCLC, 84% of which are exon 19 deletions (Ex19del)/exon 21 substitutions (L858R). Un...
Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma [0.03%]
FOLFIRINOX、改良FOLFIRINOX以及吉西他滨联合白蛋白结合型紫杉醇一线治疗转移性胰腺导管腺癌的成本分析
Syvart Dennen,Marty Masek,Paul Cockrum et al.
Syvart Dennen et al.
Background: Further research is needed to determine real-world costs of first-line (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) with FOLFIRINOX (FFX), modified FFX (mFFX), and gemcitabine with nab...
Erratum: Characteristics and Comorbidities Influencing Mortality Risk Among Hereditary Angioedema Patients [0.03%]
遗传性血管水肿患者的特征和共病对死亡风险的影响：勘误表
Subhan Khalid,Alan T Hitch
Subhan Khalid
[This corrects the article DOI: 10.36469/jheor.2025.141747.]. Keywords: Bayesian networks; directed acyclic ...
Erratum: Effect of Fresh Frozen Plasma Infusion on Hospital Length of Stay for Patients With Hereditary Angioedema [0.03%]
致读者：关于新鲜冷冻血浆输注对遗传性血管水肿患者住院时间影响的更正通知
Subhan Khalid,Alan T Hitch
Subhan Khalid
[This corrects the article DOI: 10.36460/jheor.2025.141471.]. Keywords: Bayesian additive regression trees; ...
Published Erratum
Journal of health economics and outcomes research. 2025 Aug 21;12(2):143440. DOI: 2025
Real-World Prevalence and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors in the US: A Retrospective Claims Database Analysis [0.03%]
美国接受C5抑制剂治疗的阵发性夜间血红蛋白尿患者的患病率和结局：一项回顾性理赔数据库分析
Srinivas K Tantravahi,Dominick Latremouille-Viau,Raj Desai et al.
Srinivas K Tantravahi et al.
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder with C5 inhibitors (C5i), eculizumab and ravulizumab, being part of current treatment options. ...